Associated Papers
Structural pharmacology of SV2A reveals an allosteric modulation mechanism in the major facilitator superfamily.
Pidathala S et al.
Nature Communications, 2025
41315229 (PubMed )
Supplement: 41467_2025_65781_MOESM4_ESM.xlsx › Figure_2B
Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A).
Mittal A et al.
Proceedings of the National Academy of Sciences of the United States of America, 2025
Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsants.
Mittal A et al.
Nature Structural & Molecular Biology, 2024
Further evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
Wood MD et al.
Epilepsia, 2018
Select a paper to view details